Serum Markers of Necrotizing Enterocolitis
- 1 December 2017
- journal article
- review article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 65 (6) , E120-E132
Abstract
Objective: The aim of the study was to systematically review the diagnostic utility of serum biomarkers for the diagnosis of necrotizing enterocolitis (NEC).Methods: We conducted an electronic and manual search of the available evidence. We included studies reporting data on the diagnostic accuracy of “serum” biomarkers for the diagnosis of NEC, available until January 2016.Results: We selected 22 studies from the 1296 articles retrieved. Only S100 A8/A9 protein and apolipoprotein‐CII showed high sensitivity (100% and 96.4%, respectively) and specificity (90% and 95%, respectively) in the studies using Bell stage II NEC as target condition. High sensitivity and specificity were reported for interleukin‐10 (100% and 90%), interleukin1‐receptor antagonist (100% and 91.7%), intestinal fatty acid–binding protein (100% and 91%) and ischemia‐modified albumin (94.7% and 92%), when tested to predict the evolution from definite to advanced NEC. Given the amount of uncertainty, the limited availability of data and heterogeneity among the populations in the different studies, we were unable to perform a meta‐analysis. Major concerns about the applicability stemmed from the spectrum of patients enrolled and the inclusion of diseases different from Bell stage ≥2 NEC as target conditions.Conclusions: We identified only few markers with good diagnostic accuracy and found an overall low quality of the studies on serum NEC biomarkers. In conclusion, data supporting their use are insufficient.Keywords
This publication has 54 references indexed in Scilit:
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitisEarly Human Development, 2011
- Serum Calprotectin: An Antimicrobial Peptide as a New Marker For the Diagnosis of Sepsis in Very Low Birth Weight NewbornsJournal of Immunology Research, 2011
- Necrotizing EnterocolitisNew England Journal of Medicine, 2011
- Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infantsJournal of Clinical Investigation, 2010
- Neonatal Onset Intestinal Failure: An Italian Multicenter StudyThe Journal of Pediatrics, 2008
- Plasma intestinal fatty acid binding protein in neonates with necrotizing entercolitis: A pilot studyJournal of Pediatric Surgery, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemiaSurgery, 1997
- Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitisThe Journal of Pediatrics, 1990